MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1016/j.ebiom.2025.105887

Медицинская библиотека · EBioMedicine · 2025

The role of interleukin-6 signalling in pleural infection: observational and genetic analyses.

Argyriou Amerikos, Robbins Alex, Scott Rachel, Chalmers Jodie, Wright Harrison I W, Beaumont Robin N, Elvers Karen T, Weedon Michael N, Maskell Nick A, Arnold David T, Hamilton Fergus W

СтатьяНаблюдательное исследованиеПеревод пока не подготовлен

Аннотация

BACKGROUND

Pleural infection is associated with marked local and systemic inflammation leading to significant morbidity. It may be possible to therapeutically augment this response and interleukin-6 is a key signalling cascade in inflammatory pathologies.

METHODS

We performed a prospective observational study recruiting patients with pleural effusions secondary to infection and measured interleukin-6 in matched pleural fluid and serum (n = 76). We subsequently performed a large-scale, two sample Mendelian Randomisation study (1601 cases and 830,709 controls), using genetic variation at IL6R to proxy the effect of interleukin-6 inhibition on pleural infection and overcome confounding inherent in observational analyses.

FINDINGS: Pleural interleukin-6 levels in infection were 5000-fold higher than matched serum levels (median 72,752 pg/ml vs. 15 pg/ml). Pleural interleukin-6 predicted systemic inflammation (neutrophil count, C- reactive protein), correlated with clinical markers of disease severity (effusion size, pH, glucose), and was strongly associated with length of hospital stay. In Mendelian randomisation analyses, interleukin-6 inhibition was predicted to have a large protective effect on the incidence of infection (OR 0.23; 95% CI 0.14-0.39 per standard deviation decrease in C- reactive protein). The effect size was larger than that seen in COVID-19 and coronary artery disease, where interleukin-6 inhibition has been successful in trials.

INTERPRETATION: Multiple lines of evidence suggest pleural interleukin-6 drives pathology in pleural infection. Targeting interleukin-6 may hold promise and should be considered in randomised trials.

FUNDING: This study has been funded by the National Institutes of Health and Care Research Bristol Biomedical Research Centre.

Для цитирования: Argyriou Amerikos, Robbins Alex, Scott Rachel, Chalmers Jodie, Wright Harrison I W, Beaumont Robin N, Elvers Karen T, Weedon Michael N, Maskell Nick A, Arnold David T, Hamilton Fergus W. The role of interleukin-6 signalling in pleural infection: observational and genetic analyses.. EBioMedicine. 2025. DOI: 10.1016/j.ebiom.2025.105887.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.